W.O.M. World of Medicine AG

euro adhoc: W.O.M. World of Medicine AG
Financial Figures/Balance Sheet
2007 targets exceeded once again: 15.8% growth in sales and 16.5% pre-tax sales yield

@@start.t1@@--------------------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc. The issuer is responsible   for the content of this announcement. --------------------------------------------------------------------------------@@end@@

annual report

14.03.2008

The stock-listed medical device technology manufacturer WORLD OF MEDICINE achieved a 15.8% growth in sales to TE35,746 for fiscal year 2007. Its pre-tax sales yield equaled 16.5%. In October 2007, the Management Board projected an increase in sales of at least 10% to more than E34 million, and a pre-tax sales yield of at least 13.0%. Strategically significant product launches contributed to the favorable business performance. In addition, one-time earnings from the sale of former subsidiary, IB Laser AG, added E1.1 million before taxes.

@@start.t2@@|                              |2007                        |2006                        Change                    |
|Sales                      |TE35,746                 |TE30,859                 |+ 15.8%                 |
|EBT                         |TE5,892                  |TE2,678                 |+TE3,214                 |
|Pre-tax sales yield|16.5 %                    |8.7 %                      |> 100%                  |
|Earnings per share |E0.80                      |E0.29                      |> 100%                  |

A pre-tax sales yield of 11% is projected for 2008, and an increase in sales of 7%. The Management Board, however, may pursue further investment in future- oriented projects. If necessary, it will also accept a temporary reduction of the sales yield in order to accomplish these future goals.@@end@@

Today at 10.30 a.m. CET, WORLD OF MEDICINE invites you to a telephone conference on the annual figures for 2007 (Financial Statements Press Conference). Please direct your registration for this event to the Company at stefanie.gehrke@womcorp.com.

The Group Annual Financial Report with the full Consolidated Financial Statements for fiscal year 2007 will become available to the public on March 20th at the following link www.world-of- medicine.com/2007/annualfinancialreport/index.htm.

The Management Board

@@start.t3@@end of announcement                                                 euro adhoc
--------------------------------------------------------------------------------@@end@@

ots Originaltext: W.O.M. World of Medicine AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Stefanie Gehrke, IR/PR, Fon +49 (0) 30 399 81 566, Fax: +49 (0) 30 399 81 641,
E-mail: stefanie.gehrke@womcorp.com

Branche: Pharmaceuticals
ISIN:      DE0006637390
WKN:        663739
Index:    CDAX, Prime All Share, Technologie All Share
Börsen:  Börse Frankfurt / regulated dealing/prime standard
              Börse Berlin / free trade
              Börse Hamburg / free trade
              Börse Stuttgart / free trade
              Börse Düsseldorf / free trade
              Börse München / free trade



Weitere Meldungen: W.O.M. World of Medicine AG

Das könnte Sie auch interessieren: